Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 19 min ago
Peer-reviewedCC BYDiagnostics (Basel, Switzerland)

Limited Incremental Value of Six Haemogram-Derived Inflammatory Indices for Detecting Endometrial Carcinoma and Intraepithelial Neoplasia in Abnormal Uterine Bleeding: A Case-Control Study.

  1. 1Department of Obstetrics and Gynaecology, Haseki Training and Research Hospital, University of Health Sciences, 34265 Istanbul, Türkiye.
  2. 2Department of Obstetrics and Gynaecology, Denizli Çal State Hospital, 20700 Denizli, Türkiye.
  3. 3Department of Obstetrics and Gynaecology, Osmaniye Training and Research Hospital, University of Health Sciences, 80010 Osmaniye, Türkiye.

Abstract

Background/Objectives: Haemogram-derived inflammatory indices are proposed as inexpensive markers of endometrial neoplasia, but almost all supporting evidence is prognostic, from women already known to have carcinoma. We compared six indices head-to-head and asked whether any improved discrimination beyond a clinical model of age, menopausal status, endometrial thickness and metabolic comorbidity. Methods: In this single-centre retrospective case-control study, all women with endometrial intraepithelial neoplasia (EIN) or uterine malignancy on curettage for abnormal uterine bleeding (January 2021-June 2026) were identified (136 cases); 272 benign controls were drawn at a fixed 1:2 ratio. Indices were recalculated de novo from raw differential counts. Each log-transformed index was added singly to the fixed model; the likelihood-ratio test was the primary test and the change in C-statistic (ΔC) the effect measure, with ΔC ≥ 0.02 taken as clinically relevant, and performance was internally validated by bootstrapping and cross-validation. Results: Cases were 93 carcinomas and 43 EINs. Age (AUC 0.792, 95% CI 0.744-0.841) and endometrial thickness (0.749, 0.697-0.800) discriminated better than any index; SIRI was best (0.621, 0.564-0.678) and PLR did not discriminate (0.510). The clinical model reached a C-statistic of 0.882 (0.844-0.919), inflated by design; optimism-corrected calibration slope 0.963. No index remained significant after adjustment (smallest p = 0.141); the largest ΔC was +0.0042 (-0.0027 to +0.0111). The six log-indices are algebraically dependent, so the joint model used an identifiable four-index basis; it added +0.0064 (χ²₄ = 4.48, p = 0.345), an increment that vanished on validation (optimism-corrected -0.0001; cross-validated +0.0010, -0.0076 to +0.0097). Accuracy at the Youden cut-off was 83.5% (clinical) and 81.7-84.2% (index models). Twelve sensitivity analyses agreed. Conclusions: None of the six indices provided detectable incremental discrimination once age, menopausal status and endometrial thickness were accounted for; their univariable associations reflect the clinical profile of affected women rather than an independent biological signal.

Related

  1. Predicting concurrent endometrial carcinoma in women with endometrial intraepithelial neoplasia without preoperative suspicion of malignancy
    Gil Zeevi, Effi Yeoshoua, Chani Dahan +7
    Gynecologic oncology reportsPeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsEurope PMCEurope PMCPMC
  2. Sentinel Lymph Node Assessment in Endometrial Intraepithelial Neoplasia/Atypical Endometrial Hyperplasia: An Updated Systematic Review and Meta-Analysis.
    Pei-Chen Li, Dah-Ching Ding
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsEurope PMC
  3. Beyond Molecular Classification: The Incremental Value of Prognostic Biomarkers in Endometrial Cancer
    Vlad Gabriel Tirnovanu, Iustina Petra Solomon Condriuc, Raluca Anamaria Mogos +6
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0Full textObstetrics, gynaecology & paediatricsCrossrefEurope PMC
  4. Postoperative C-Reactive Protein as a Marker of the Early Inflammatory Response in Robotic Versus Laparoscopic Minimally Invasive Surgery for Endometrial Cancer: A Propensity Score-Matched Analysis
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Association and incremental predictive performance of preoperative nutritional and inflammatory indices for postoperative ICU admission after hepatobiliary and pancreatic tumor surgery
    Longyun Ou, Haozhu Wang
    Frontiers in NutritionPeer-reviewedCC BY 4.0Full textOncologyPMC
BibTeX
@article{cakmak2026limited,
  title = {{Limited Incremental Value of Six Haemogram-Derived Inflammatory Indices for Detecting Endometrial Carcinoma and Intraepithelial Neoplasia in Abnormal Uterine Bleeding: A Case-Control Study.}},
  author = {Senem Karacabey Cakmak and Busra Seker Atas and Ezgi Gungor and Kubra Sevim Pehlivan},
  journal = {Diagnostics (Basel, Switzerland)},
  year = {2026},
  month = oct,
  doi = {10.3390/diagnostics16193219},
  url = {https://europepmc.org/article/MED/42882374},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Limited Incremental Value of Six Haemogram-Derived Inflammatory Indices for Detecting Endometrial Carcinoma and Intraepithelial Neoplasia in Abnormal Uterine Bleeding: A Case-Control Study.
AU  - Senem Karacabey Cakmak
AU  - Busra Seker Atas
AU  - Ezgi Gungor
AU  - Kubra Sevim Pehlivan
PY  - 2026
DA  - 2026/10/05
JO  - Diagnostics (Basel, Switzerland)
DO  - 10.3390/diagnostics16193219
UR  - https://europepmc.org/article/MED/42882374
AB  - Background/Objectives: Haemogram-derived inflammatory indices are proposed as inexpensive markers of endometrial neoplasia, but almost all supporting evidence is prognostic, from women already known to have carcinoma. We compared six indices head-to-head and asked whether any improved discrimination beyond a clinical model of age, menopausal status, endometrial thickness and metabolic comorbidity. Methods: In this single-centre retrospective case-control study, all women with endometrial intraepithelial neoplasia (EIN) or uterine malignancy on curettage for abnormal uterine bleeding (January 2021-June 2026) were identified (136 cases); 272 benign controls were drawn at a fixed 1:2 ratio. Indices were recalculated de novo from raw differential counts. Each log-transformed index was added singly to the fixed model; the likelihood-ratio test was the primary test and the change in C-statistic (ΔC) the effect measure, with ΔC ≥ 0.02 taken as clinically relevant, and performance was internally validated by bootstrapping and cross-validation. Results: Cases were 93 carcinomas and 43 EINs. Age (AUC 0.792, 95% CI 0.744-0.841) and endometrial thickness (0.749, 0.697-0.800) discriminated better than any index; SIRI was best (0.621, 0.564-0.678) and PLR did not discriminate (0.510). The clinical model reached a C-statistic of 0.882 (0.844-0.919), inflated by design; optimism-corrected calibration slope 0.963. No index remained significant after adjustment (smallest p = 0.141); the largest ΔC was +0.0042 (-0.0027 to +0.0111). The six log-indices are algebraically dependent, so the joint model used an identifiable four-index basis; it added +0.0064 (χ²₄ = 4.48, p = 0.345), an increment that vanished on validation (optimism-corrected -0.0001; cross-validated +0.0010, -0.0076 to +0.0097). Accuracy at the Youden cut-off was 83.5% (clinical) and 81.7-84.2% (index models). Twelve sensitivity analyses agreed. Conclusions: None of the six indices provided detectable incremental discrimination once age, menopausal status and endometrial thickness were accounted for; their univariable associations reflect the clinical profile of affected women rather than an independent biological signal.
SN  - 2075-4418
ER  -